Natale and Raquer [14] do not provide a clear stratification of studies included in the review; only 5 of 33 were mentioned reporting correlation with skin cancer, but the data presentation form does not consent to correlate the risk of cancer to a specific XP or XP-CS complementation group nor to have a comprehensive survey on the entire data collection. The gene discussed is CS; the disease is cancer.